Project Grant R15AI188560
Award Date
12/20/24
Completion Date
11/30/27
Dollars Obligated
$474K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Rowan University (DMDEQP66JL85)
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Glassboro, NJ 08028, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $383,750 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Nebraska Medical Center (UNMC) to discover novel antimicrobial peptides that can effectively eliminate drug-resistant gram-negative bacteria. The project aims to elucidate the structure-activity relationship, toxicity, pharmacokinetics, and in vivo efficacy of a novel antimicrobial peptide called Verine...
This $453,900 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is funding research to develop a genome editing platform using broadly functioning phage recombinases, which can be used to genetically manipulate a wide range of bacterial species, including clinically relevant pathogens. The goal is to enable direct investigation of the genetic elements driving bacterial...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $569,210 to the University of Colorado Boulder to characterize the biochemical mechanisms of antimicrobial resistance in Gram-negative bacteria. The project aims to structurally and functionally analyze three key enzymes involved in modifying the bacterial cell membrane component lipid A, which confers...
This $361,237 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop a new class of species-specific antimicrobial peptides called PNA-STAMPS to target Streptococcus pneumoniae (Spn), a major human pathogen. The project builds on preliminary data showing that fusing a broad-spectrum antimicrobial peptide (AMP) to an Spn-specific secreted peptide can selectively eliminate...
This $642,775 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research to accelerate the discovery of novel antifungal peptides using one-bead one-compound (OBOC) combinatorial technology. The University of California, Davis will conduct high-throughput screening of chemically synthesized peptide libraries to identify membrane-active antifungal peptides that can...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $299,995 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Xiretsa Inc., a minority-owned small business located in Santa Barbara, CA. The grant will fund the development of a novel class of antimicrobial compounds called Anti-Infective Conjugated Electrolytes (ACEs) that target the bacterial cell membrane to address the growing threat of antimicrobial resistance. The project...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $158,800.00 to The Curators of the University of Missouri, doing business as the University of Missouri at Kansas City (UMKC), for the period of September 1, 2024 to August 31, 2026. The funding will support research to investigate the structure, function, and therapeutic potential of cyclic beta-hairpin...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $593,860 Project Grant to the University of Massachusetts (UMass) to develop polymer-phage nanoparticle conjugates for treating antibiotic-resistant wound biofilm infections. The project aims to create new polymers that can encapsulate phages to enhance their ability to penetrate and eradicate biofilms, a key challenge in phage therapy. Specific...
The University of Texas Southwestern Medical Center was awarded a $254,478 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, with a performance period from May 16, 2025 to April 30, 2027, aims to determine the mechanisms of resistance to peptide-phosphorodiamidate morpholino oligomer (PPMO) antibacterial compounds in key Gram-negative pathogens including Klebsiella...
This federal Project Grant award for $637,275 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to uncover the mechanisms behind how gram-negative bacterial pathogens rapidly develop tolerance to chemical stressors like antibiotics. The research aims to determine how bacteria can inhibit the functioning of existing porin proteins in their outer membrane within minutes of exposure to...